Pharma is undoubtedly experiencing an evolution as new digital platforms and technologies enter our market. The need for refined marketing techniques in key healthcare areas such as compliance and the delivery of treatment, in combination with the changing role of the sales force, are setting in motion innovation to improve conversations between healthcare professionals and patients.
Over this past year,we have experienced an unnatural withdrawal from society. Inevitably, perpetuated feelings of loneliness, uncertainty, and loss of control during this time have taken a toll on mental health and well-being of many around the globe. If true for the general population, this phenomenon hits harder for those living with multiple sclerosis.
Approved email can be highly effective – empowering reps with pre-approved content to engage HCPs. And it’s definitely been proving its worth right now with face-to-face HCP meetings being restricted. But it still has to be done right.
We all know how much the pandemic has impacted the industry’s ability to engage with healthcare professionals (HPCs) and the extent to which companies have switched to digital to maintain HCP relationships. What interesting, however, is where those investments were being directed – and how that might change in the future.
Remote detailing, and generally any kind of remote engagement, has been increasing steadily over the last decade. It was clear that it would have a big part to play in pharma sales and marketing in the future. Last year turbocharged that. Now it’s an essential channel – and is growing exponentially.
You’ve likely heard a lot about modular content over the last few years. It’s often described as being the future of content in pharma. But why? What exactly does it give you that traditional content doesn’t?
Many life sciences companies are experiencing the same problem: global brand strategies are often excellent but aren’t having the expected impact. So, what’s happening?
After years getting the platforms in place, companies are now speeding up their innovation to make the most of every opportunity for direct contact with healthcare professionals.
WebSummit gathered founders and CEOs of the world’s biggest technology companies, together with fast-growing startups, innovators and influencers. Here's our key trends.
Those that truly understand the needs and interests of HCPs and the trends in their behavior see increasing returns from personalised and data driven marketing that provide an effective advantage over their competitors.
In our new e-book, we show how you can take your e-detailing content and make it available to HCPs 24/7 – without losing the ‘guided’ experience that makes it so valuable.
If you have ever tried to localise marketing or sales materials – brochures, presentations, whitepapers, etc. – “complexity” might be one word that comes to mind.
In this article we will try to answer the questions of why it is important that pharma build its digital competences on all level of the organisation and how to go about it.
Do you know how to make your eDetailing content available to HCPs 24/7 – without losing the ‘guided’ experience that makes it so valuable?
Digital transformation has been discussed for a decade now, so we’re all aware of the value-potential that digital marketing initiatives can offer us.
Research from Salesforce shows that 75% of consumers expect a consistent experience wherever they engage with brands – be it through social media, mobile, or even in person.
How do you support healthcare professionals while corona virus restrictions are in place? Two solutions that are particularly relevant to pharma right now are ‘remote engagement’ and ‘self-detailing’.
